AIAI market cap is $122M, but its revenue base so far is minimal (less than $1M). Risk and expectations are extremely high here. It has a bit of cash ($1.3M) and has lost money, with negative cash flow, since inception. Insiders own 17% and have been net buyers this year. Focusing on using AI to better help healthcare patients, valuation and expectations are a bit too high for us here (in addition to risks). There is very little to analyze. AIDX would have some similarities in areas of expected operations; it has expected $136M revenue this year.
5i Research Answer: